BIGG

Início > Guias GRADE > Resultado da busca

Resultados: 2

Tafasitamab with lenalidomide for treating relapsed or refractory diffuse large B-cell lymphoma

England. National Institute for Health and Care Excellence.
People with relapsed or refractory diffuse large B-cell lymphoma who cannot have an autologous stem cell transplant usually have polatuzumab vedotin plus rituximab and bendamustine. The clinical evidence is from a small study that did not directly compare tafasitamab plus lenalidomide with any other trea...
Linfoma Difuso de Grandes Células B/tratamento farmacológico, Lenalidomida/uso terapêutico, Anticorpos Monoclonais/uso terapêutico, Fatores Imunológicos/uso terapêutico
Texto completo

SIE, SIES, GITMO evidence-based guidelines on novel agents (thalidomide, bortezomib, and lenalidomide) in the treatment of multiple myeloma

Barosi, Giovanni; Merlini, Giampaolo; Atto, Billio; Boccadoro, Mario; Corradini, Paolo; Marchetti, Monia; Massaia, Massimo; Tosi, Patrizia; Palumbo, Antonio; Cavo, Michele; Tura, Sante.
Ann. hematol; 91 (6), 2012
In this project, we produced drug-specific recommendations targeting the use of new agents for multiple myeloma (MM). We used the GRADE (Grades of Recommendation, Assessment, Development, and Evaluation) system which separates the judgments on quality of evidence from the judgment about strength of recom...
Protocolos de Quimioterapia Combinada Antineoplásica, Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem, Ácidos Borônicos/uso terapêutico, Bortezomib/uso terapêutico, Hematologia/legislação & jurisprudência, Hematologia/métodos, Lenalidomida/uso terapêutico, Mieloma Múltiplo/patologia, Gradação de Tumores, Pirazinas/administração & dosagem, Sociedades Médicas/legislação & jurisprudência, Talidomida/uso terapêutico
Texto completo